Mar 3, 2017

High Risk Patients Using Anti-Factor X Anticoagulants or Vitamin K Antagonists incidents of Secondary Clot or Abnormal Uterine Bleeding with Concurrent Hormonal Birth Control Use

Melissa Stenzel '17